Rare Biomarkers Specimen Collection and Stabilization - Global Strategic Business Report

Global Rare Biomarkers Specimen Collection and Stabilization Market to Reach $78.6 Billion by 2030

The global market for Rare Biomarkers Specimen Collection and Stabilization estimated at US$31.6 Billion in the year 2022, is projected to reach a revised size of US$78.6 Billion by 2030, growing at a CAGR of 12.1% over the analysis period 2022-2030. Circulating Cell Free DNA (ccfDNA), one of the segments analyzed in the report, is projected to record 11.2% CAGR and reach US$30.8 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Circulating Tumor Cells (CTCs) segment is readjusted to a revised 12.6% CAGR for the next 8-year period.

The U.S. Market is Estimated at $9.4 Billion, While China is Forecast to Grow at 11.2% CAGR

The Rare Biomarkers Specimen Collection and Stabilization market in the U.S. is estimated at US$9.4 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$13.3 Billion by the year 2030 trailing a CAGR of 11.2% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11.1% and 9.9% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 10% CAGR.

Select Competitors (Total 32 Featured) -

• Advanced Cell Diagnostics, Inc.
• Agena Bioscience
• ANGLE plc
• ApoCell, Inc.
• AS One InternationalNTERNATIONAL
• BioChain Institute, Inc.
• Biolidics Limited
• Biomatrica
• Bio-Techne Corporation
• BioVision, Inc.
• Caltag Medsystems Limited
• Cytomark Ltd.
• DNA Genotek, Inc.
• Epic Sciences
• EpiGentek Group Inc.
• F. Hoffmann-La Roche Ltd
• Fluxion Biosciences, Inc.
• Geno Technology Inc.
• Genomax Technologies Pte Ltd.
• GILUPI GmbH
• LifeSpan BioSciences, Inc.
• MagBio Genomics Inc.
• Menarini Silicon Biosystems
• MyBioSource.com
• Norgen Biotek Corp.
• Novus Biologicals, LLC
• OraSure Technologies Inc.
• Precision for Medicine, Inc.
• Promega Corporation
• QIAGEN
• Rarecells Diagnostics SAS
• RareCyte, Inc.
• siemens Healthineers
• SiO2 Materials Science
• STEMCELL Technologies Inc.
• Streck, Inc.
• Thermo Fisher Scientific, Inc.
• Vortex Biosciences
• VyCAP B.V.

What's New?

• Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its 'bumpy' reopening; supply chain disruptions, global trade tensions; and risk of recession.
• Global competitiveness and key competitor percentage market shares
• Market presence across multiple geographies - Strong/Active/Niche/Trivial
• Online interactive peer-to-peer collaborative bespoke updates
• Access to digital archives and Research Platform
• Complimentary updates for one year